111, Inc. Sponsored ADR (NASDAQ:YI – Get Free Report) Director Jian David Sun sold 115,440 shares of the stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $0.22, for a total transaction of $25,396.80. Following the completion of the transaction, the director directly owned 583,111 shares of the company’s stock, valued at approximately $128,284.42. The trade was a 16.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Jian David Sun also recently made the following trade(s):
- On Tuesday, June 9th, Jian David Sun sold 12,000 shares of 111 stock. The shares were sold at an average price of $0.23, for a total transaction of $2,760.00.
- On Wednesday, May 27th, Jian David Sun sold 70,440 shares of 111 stock. The shares were sold at an average price of $0.25, for a total transaction of $17,610.00.
- On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total transaction of $7,905.60.
111 Trading Down 0.9%
Shares of NASDAQ:YI opened at $4.36 on Thursday. 111, Inc. Sponsored ADR has a 12 month low of $2.48 and a 12 month high of $11.17. The company has a 50-day moving average price of $6.00 and a 200 day moving average price of $5.64. The company has a market cap of $38.30 million, a price-to-earnings ratio of -3.11 and a beta of 0.60.
Wall Street Analysts Forecast Growth
111 Company Profile
111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.
111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.
Featured Articles
- Five stocks we like better than 111
- As Shares Fall, Analyst Are Boosting their Broadcom Price Targets
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
